# Falcon III Ventures

> Falcon III Ventures is a VC fund backing Biotechnology and Bioinformatics. See 3 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: VC Fund
- Location: Boston, United States
- Total investments: 3
- Last investment: Dec 2019
- Lead investor: 100%
- Last updated: Sep 2026

Falcon III Ventures is a VC fund in Boston focused on Biotechnology and Bioinformatics. Falcon III Ventures Boston-based biotech Venture capital.

## Contacts

5 contacts available for Falcon III Ventures. Shizune tracks 1 team members at Falcon III Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/falcon-iii-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Bioinformatics | 2 | 67% |
| Machine Learning | 2 | 67% |
| Artificial Intelligence | 2 | 67% |
| Genetics | 1 | 33% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Funding Round | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Switzerland | 1 | 33% |
| United States | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Yiannis Monovoukas | Co-Founder and Managing Partner | 0 | https://shizune.co/investors/profile/yiannis-monovoukas |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Biotia | Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid and precise infectious disease discovery. Their software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes. | $2.4M | Seed | Dec 10, 2019 |  |
| InterAx Biotech Ltd | InterAx is pioneering a new scientific discipline at the intersection of biology and machine learning with the aim to be on the forefront of the digital transformation of drug discovery and ultimately improve human health. InterAx is a Swiss biotech company, spinoff of ETH Zurich and Paul Scherrer Institute incorporated in 2016, reinventing drugdiscovery to significantly reduce the time and costs associated with the discovery and development of new drugs for a wide array of human diseases. Our solution lies in the combination of in-house experimental assays, mathematical modelling and artificial intelligence to analyze and predict the physiological response of cells to drugs. We are able to describe the complex action of drug molecules in their cellular context and to guide the optimization of drug candidates to achieve a specific cellular response leading to higher efficacy and reduced side effects in humans, thus significantly accelerating drug discovery and de-risking clinical trials. | $3.5M |  | Jan 15, 2019 |  |
| InterAx Biotech Ltd | InterAx is pioneering a new scientific discipline at the intersection of biology and machine learning with the aim to be on the forefront of the digital transformation of drug discovery and ultimately improve human health. InterAx is a Swiss biotech company, spinoff of ETH Zurich and Paul Scherrer Institute incorporated in 2016, reinventing drugdiscovery to significantly reduce the time and costs associated with the discovery and development of new drugs for a wide array of human diseases. Our solution lies in the combination of in-house experimental assays, mathematical modelling and artificial intelligence to analyze and predict the physiological response of cells to drugs. We are able to describe the complex action of drug molecules in their cellular context and to guide the optimization of drug candidates to achieve a specific cellular response leading to higher efficacy and reduced side effects in humans, thus significantly accelerating drug discovery and de-risking clinical trials. | $3M | Venture - Series Unknown | Jan 15, 2019 |  |

3 of 3 investments shown.

## Co-investors
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund, 3 deals together
- [Aargauische Kantonalbank](https://shizune.co/investors/profile/aargauische-kantonalbank) — VC Fund, 2 deals together
- [Bernina BioInvest](https://shizune.co/investors/profile/bernina-bioinvest) — VC Fund, 2 deals together
- [Business Angels Club Aargau](https://shizune.co/investors/profile/business-angels-club-aargau) — VC Fund, 2 deals together
- [Verve Ventures](https://shizune.co/investors/profile/verve-ventures) — VC Fund, 2 deals together
- [Hyperplane](https://shizune.co/investors/profile/hyperplane-venture-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

### Similar country
- [SICTIC](https://shizune.co/investors/profile/sictic) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund

## Featured in investor lists
- [Machine Learning Investors in Switzerland](https://shizune.co/investors/machine-learning-investors-switzerland)
- [Machine Learning VC Funds in Switzerland](https://shizune.co/investors/machine-learning-vc-funds-switzerland)

## FAQ

### What does Falcon III Ventures invest in?

Falcon III Ventures invests primarily in Biotechnology, Bioinformatics and Machine Learning startups, most often at Seed and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Falcon III Ventures?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Falcon III Ventures?

The team at Falcon III Ventures includes Yiannis Monovoukas (Co-Founder and Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co